Philippe Rousseau
Keine laufenden Positionen mehr
Karriereverlauf von Philippe Rousseau
Ehemalige bekannte Positionen von Philippe Rousseau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOPHYTIS S.A. | Verwaltungsdirektor | 05.04.2022 | 22.05.2023 |
Finanzdirektor/CFO | 05.04.2022 | 22.05.2023 | |
Investor Relations Kontakt | 05.04.2022 | 22.05.2023 | |
PHERECYDES PHARMA | Direktor/Vorstandsmitglied | 24.06.2020 | 19.05.2022 |
Geschäftsführer | 24.06.2020 | 19.05.2022 | |
Finanzdirektor/CFO | 24.06.2020 | 19.05.2022 | |
Investor Relations Kontakt | 24.06.2020 | 19.05.2022 | |
Abcdx SA
Abcdx SA Medical SpecialtiesHealth Technology Abcdx SA is a Swiss-based company that specializes in the discovery, clinical validation, and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries. The company is based in Geneva, Switzerland. The company combines its unique expertise in brain biomarker discovery, awareness, and clinical validation. Abcdx was founded by Charles Sanchez and Joan Montaner, and Charles Sanchez has been the CEO since incorporation. | Corporate Officer/Principal | 01.01.2019 | 01.01.2020 |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Vorstandsvorsitzender | 01.01.2013 | 01.01.2018 |
Anesten LLC | Corporate Officer/Principal | 01.01.2010 | 01.01.2018 |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Finanzdirektor/CFO | 09.09.2009 | 28.05.2013 |
Investor Relations Kontakt | 08.09.2009 | 28.05.2013 | |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Vorstandsvorsitzender | 01.01.2003 | 26.06.2009 |
Finanzdirektor/CFO | 01.01.2003 | 26.06.2009 | |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Finanzdirektor/CFO | - | - |
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Corporate Officer/Principal | 01.01.1998 | - |
░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Philippe Rousseau
Hautes Etudes Commerciales | Graduate Degree |
École des Hautes Études Commerciales de Paris | Masters Business Admin |
Statistik
International
Frankreich | 9 |
Vereinigte Staaten | 3 |
Belgien | 2 |
Operativ
Director of Finance/CFO | 5 |
Chief Executive Officer | 3 |
Investor Relations Contact | 3 |
Sektoral
Health Technology | 8 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOPHYTIS S.A. | Health Technology |
Private Unternehmen | 9 |
---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Vivalis SA
Vivalis SA Pharmaceuticals: OtherHealth Technology Vivalis SA manufactures human and animal vaccines. The firm specializes in the research and development of vaccines and antiviral molecules, as well as in recombinant therapeutic protein and monoclonal antibody expression systems development. The firm's embryonic stem cells are used for practical applications in human and animal health. It also helps its clients in a case by case basis for the development of processes in the frame of service agreement. The company was founded in April 1999 and is headquartered in France. | Health Technology |
COPEBAT SA
COPEBAT SA Wholesale DistributorsDistribution Services COPEBAT SA supplies storage and distribution of materials for carpenters. It wholesales wood, construction materials, and sanitary systems. The company was founded in March 2003 and is headquartered in Vineuil, France. | Distribution Services |
Pherecydes Pharma SA
Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Pherecydes Pharma SA is a biotechnology company, which engages in the research and development of anti-infective therapies based on the use of bacteriophages. It develops phage treatments of bacterial infections. The company was founded by Jerome Gabard and Manuel Gea in December 2006 and is headquartered in Romainville, France. | Health Technology |
Abcdx SA
Abcdx SA Medical SpecialtiesHealth Technology Abcdx SA is a Swiss-based company that specializes in the discovery, clinical validation, and commercialization of point-of-care diagnostics with advanced blood-based biomarkers for brain injuries. The company is based in Geneva, Switzerland. The company combines its unique expertise in brain biomarker discovery, awareness, and clinical validation. Abcdx was founded by Charles Sanchez and Joan Montaner, and Charles Sanchez has been the CEO since incorporation. | Health Technology |
Serono Genetics Institute SA
Serono Genetics Institute SA Miscellaneous Commercial ServicesCommercial Services Part of Merck KGaA, Serono Genetics Institute SA is a French biotechnology company specializing in synthetic DNA and genetic analysis. The company is based in Paris, France. The company was founded in 1989 by Pascal Brandys. Serono Genetics Institute was acquired by Serono SA on September 23, 2002 for $65.82 million. | Commercial Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France. | Health Technology |
Anesten LLC | |
Therabron Therapeutics, Inc.
Therabron Therapeutics, Inc. BiotechnologyHealth Technology Therabron Therapeutics, Inc. provides biotechnology services. It is focused on the advancement of respiratory therapeutics with disease-modifying potential. The company was founded by Aprile Pilon in 2007 and is headquartered in Rockville, MD. | Health Technology |
- Börse
- Insiders
- Philippe Rousseau
- Erfahrung